Mita Y - Search Results

1

Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer.

Koshizuka K, Sakurai D, Sunagane M, Mita Y, Hamasaki S, Suzuki T, Kikkawa N, Nakano M, Hanazawa T. Koshizuka K, et al. Among authors: mita y. Clin Case Rep. 2020 Dec 18;9(2):848-852. doi: 10.1002/ccr3.3695. eCollection 2021 Feb. Clin Case Rep. 2020. PMID: 33598257 Free PMC article.

2

A case of jugular bulb diverticulum causing pulsatile tinnitus.

Fukumoto I, Yamasaki K, Yonekura S, Iinuma T, Mita Y, Sonobe Y, Hanazawa T. Fukumoto I, et al. Among authors: mita y. Clin Case Rep. 2021 Sep 21;9(9):e04745. doi: 10.1002/ccr3.4745. eCollection 2021 Sep. Clin Case Rep. 2021. PMID: 34584695 Free PMC article.

3

Preoperative simulation using three-dimensional printer in four temporal bone surgeries.

Fukumoto I, Mita Y, Shimmi R, Sonobe Y, Iinuma T, Yamasaki K, Yonekura S, Nemoto T, Hanazawa T. Fukumoto I, et al. Among authors: mita y. Clin Case Rep. 2023 May 12;11(5):e7135. doi: 10.1002/ccr3.7135. eCollection 2023 May. Clin Case Rep. 2023. PMID: 37192847 Free PMC article.

4

Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.

Mita Y, Kimura MY, Hayashizaki K, Koyama-Nasu R, Ito T, Motohashi S, Okamoto Y, Nakayama T. Mita Y, et al. Int Immunol. 2018 Nov 14;30(12):559-567. doi: 10.1093/intimm/dxy050. Int Immunol. 2018. PMID: 30085193

5

CD69 prevents PLZF^hi innate precursors from prematurely exiting the thymus and aborting NKT2 cell differentiation.

Kimura MY, Igi A, Hayashizaki K, Mita Y, Shinzawa M, Kadakia T, Endo Y, Ogawa S, Yagi R, Motohashi S, Singer A, Nakayama T. Kimura MY, et al. Among authors: mita y. Nat Commun. 2018 Sep 14;9(1):3749. doi: 10.1038/s41467-018-06283-1. Nat Commun. 2018. PMID: 30218105 Free PMC article.

6

CD69 Imposes Tumor-Specific CD8+ T-cell Fate in Tumor-Draining Lymph Nodes.

Koyama-Nasu R, Kimura MY, Kiuchi M, Aoki A, Wang Y, Mita Y, Hasegawa I, Endo Y, Onodera A, Hirahara K, Motohashi S, Nakayama T. Koyama-Nasu R, et al. Among authors: mita y. Cancer Immunol Res. 2023 Aug 3;11(8):1085-1099. doi: 10.1158/2326-6066.CIR-22-0406. Cancer Immunol Res. 2023. PMID: 37216576

7

Multidisciplinary treatment for small cell carcinoma of the bladder: a case report.

Mita Y, Teishima J, Yao A, Uematsu R, Yoshii T, Hara T, Fujisawa M, Nakamura I. Mita Y, et al. Int Cancer Conf J. 2024 Jan 24;13(2):103-107. doi: 10.1007/s13691-023-00644-4. eCollection 2024 Apr. Int Cancer Conf J. 2024. PMID: 38524643

8

Prognostic model using postoperative normalization of C-reactive protein levels in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.

Teishima J, Hirata J, Toge T, Uematsu R, Mita Y, Yoshii T, Nakamura I. Teishima J, et al. Among authors: mita y. Can Urol Assoc J. 2024 Mar;18(3):E84-E90. doi: 10.5489/cuaj.8393. Can Urol Assoc J. 2024. PMID: 38507711 Free PMC article.

9

Y chromosome haplogroup N in a Japanese population is classified into three subclades, and two DYS385 loci, a duplicated Y-STR, are duplicated again in subclade N-M1819.

Watahiki H, Fujii K, Fukagawa T, Mita Y, Kitayama T, Mizuno N. Watahiki H, et al. Among authors: mita y. Leg Med (Tokyo). 2024 Mar;67:102390. doi: 10.1016/j.legalmed.2023.102390. Epub 2023 Dec 29. Leg Med (Tokyo). 2024. PMID: 38190775

10

Ureteral obstruction following transurethral resection of bladder cancer within the Hutch's diverticulum.

Tashiro Y, Teishima J, Sakata H, Mita Y, Yao A, Nakamura I. Tashiro Y, et al. Among authors: mita y. Int Cancer Conf J. 2023 Oct 26;13(1):45-48. doi: 10.1007/s13691-023-00634-6. eCollection 2024 Jan. Int Cancer Conf J. 2023. PMID: 38187182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page